Deksametason (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "Deksametason" in Malay language version.

refsWebsite

Global rank Malay rank

64nih.gov

4^th place

14^th place

47web.archive.org

1^st place

40doi.org

2^nd place

8^th place

15wikipedia.org

low place

5europa.eu

68^th place

197^th place

5books.google.com

3^rd place

10^th place

4who.int

195^th place

103^rd place

4tga.gov.au

3,984^th place

5,878^th place

2drugs.com

399^th place

730^th place

2clincalc.com

3,912^th place

low place

2medicines.org.uk

3,823^rd place

5,861^st place

2reuters.com

49^th place

98^th place

2fda.gov

447^th place

467^th place

1handle.net

102^nd place

419^th place

1paramedic-info.com

low place

1mayoclinic.org

1,610^th place

959^th place

1sps.nhs.uk

low place

1idsociety.org

low place

1ox.ac.uk

613^th place

898^th place

1jamanetwork.com

2,650^th place

5,302^nd place

1archive.today

14^th place

79^th place

1canada.ca

1,712^th place

4,938^th place

1annals.org

low place

4,992^nd place

1time.com

61^st place

120^th place

1operationalmedicine.org

low place

1medscape.com

719^th place

1,238^th place

1harvard.edu

18^th place

46^th place

1targetcivils.in

low place

1gpni.co.uk

low place

1bbc.co.uk

8^th place

33^rd place

1wada-ama.org

9,542^nd place

3,441^st place

1wedgewoodpharmacy.com

low place

annals.org

"Syndromes of glucocorticoid resistance" (PDF). Annals of Internal Medicine. 119 (11): 1113–24. December 1993. doi:10.7326/0003-4819-119-11-199312010-00009. PMID 8239231. Diarkibkan daripada yang asal (PDF) pada 14 August 2017. Dicapai pada 4 July 2020.

archive.today

Public Health Agency of Canada (2020-11-23). "Ad-hoc COVID-19 Clinical Pharmacology Task Group: Statement on dexamethasone". Government of Canada. Diarkibkan daripada yang asal pada 27 December 2020. Dicapai pada 2022-04-01.

bbc.co.uk

"Bangladesh's dark brothel steroid secret". BBC News Online. 30 May 2010. Diarkibkan daripada yang asal pada 22 February 2012.

books.google.com

Rankovic Z, Hargreaves R, Bingham M (2012). Drug discovery and medicinal chemistry for psychiatric disorders. Cambridge: Royal Society of Chemistry. m/s. 286. ISBN 9781849733656. Diarkibkan daripada yang asal pada 5 March 2016.
Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. m/s. 485. ISBN 9783527607495. Diarkibkan daripada yang asal pada 10 January 2023. Dicapai pada 17 June 2020.
Dan L. Longo, Anthony Fauci, Dennis Kasper, Stephen Hauser, J. Jerry Jameson and Joseph Loscalzo, Harrison's Principles of Internal Medicine, 18th edition, p. 3055
Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. m/s. 366–. ISBN 978-1-4757-2085-3. Diarkibkan daripada yang asal pada 15 February 2017.
Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. m/s. 310–. ISBN 978-3-88763-075-1. Diarkibkan daripada yang asal pada 24 August 2017.

canada.ca

Public Health Agency of Canada (2020-11-23). "Ad-hoc COVID-19 Clinical Pharmacology Task Group: Statement on dexamethasone". Government of Canada. Diarkibkan daripada yang asal pada 27 December 2020. Dicapai pada 2022-04-01.

clincalc.com

"The Top 300 of 2020". ClinCalc. Diarkibkan daripada yang asal pada 12 February 2021. Dicapai pada 7 October 2022.
"Dexamethasone – Drug Usage Statistics". ClinCalc. Diarkibkan daripada yang asal pada 12 April 2020. Dicapai pada 7 October 2022.

doi.org

Jobe AH, Milad MA, Peppard T, Jusko WJ (March 2020). "Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India". Clinical and Translational Science. 13 (2): 391–99. doi:10.1111/cts.12724. PMC 7070803. PMID 31808984.
"International consensus report on the investigation and management of primary immune thrombocytopenia". Blood. 115 (2): 168–86. January 2010. doi:10.1182/blood-2009-06-225565. PMID 19846889. Unknown parameter |displayauthors= ignored (bantuan)
"Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth". European Journal of Clinical Pharmacology. 44 (3): 275–77. 1993. doi:10.1007/BF00271371. PMID 8491244.
"Corticosteroid implants for chronic non-infectious uveitis". The Cochrane Database of Systematic Reviews. 1 (1): CD010469. January 2023. doi:10.1002/14651858.CD010469.pub3. PMC 9841887 Check |pmc= value (bantuan). PMID 36645716 Check |pmid= value (bantuan).
"Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure". The Cochrane Database of Systematic Reviews. 2022 (6): CD012131. June 2022. doi:10.1002/14651858.CD012131.pub3. PMC 9169535 Check |pmc= value (bantuan). PMID 35665485 Check |pmid= value (bantuan).
"Corticosteroids for acute bacterial meningitis". Cochrane Database of Systematic Reviews. 2015 (9): CD004405. September 2015. doi:10.1002/14651858.CD004405.pub5. PMC 6491272. PMID 26362566.
"Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy". The New England Journal of Medicine. 342 (21): 1554–59. May 2000. doi:10.1056/NEJM200005253422102. PMID 10824073.
"Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications". Journal of the American College of Surgeons. 195 (5): 694–712. November 2002. doi:10.1016/s1072-7515(02)01491-6. PMID 12437261.
"Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?". J Neurooncol. 144 (2): 249–264. September 2019. doi:10.1007/s11060-019-03238-4. PMC 6700052. PMID 31346902.
"Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis". JAMA. 324 (13): 1330–1341. September 2020. doi:10.1001/jama.2020.17023. PMC 7489434. PMID 32876694. Unknown parameter |displayauthors= ignored (bantuan)
"Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic". JAMA. 324 (13): 1292–1295. September 2020. doi:10.1001/jama.2020.16747. PMID 32876693. Diarkibkan daripada yang asal pada 3 December 2020. Dicapai pada 2 September 2020.
"Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set". Critical Care. 26 (1): 236. August 2022. doi:10.1186/s13054-022-04108-8. PMC 9347163 Check |pmc= value (bantuan). PMID 35922860 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists". Intensive Care Medicine. 48 (7): 954–957. July 2022. doi:10.1007/s00134-022-06750-w. PMC 9171741 Check |pmc= value (bantuan). PMID 35670819 Check |pmid= value (bantuan).
"Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study". Critical Care. 26 (1): 176. June 2022. doi:10.1186/s13054-022-04049-2. PMC 9191402 Check |pmc= value (bantuan). PMID 35698155 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Ventilator-associated pneumonia in critically ill patients with COVID-19". Critical Care. 25 (1): 25. January 2021. doi:10.1186/s13054-021-03460-5. PMC 7797892. PMID 33430915. Unknown parameter |displayauthors= ignored (bantuan)
"Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19". Nature Medicine. 28 (1): 201–211. January 2022. doi:10.1038/s41591-021-01576-3. PMC 8799469 Check |pmc= value (bantuan). PMID 34782790 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Adverse side effects of dexamethasone in surgical patients". The Cochrane Database of Systematic Reviews. 11 (11): CD011940. November 2018. doi:10.1002/14651858.CD011940.pub3. PMC 6426282. PMID 30480776. Unknown parameter |displayauthors= ignored (bantuan)
"Syndromes of glucocorticoid resistance" (PDF). Annals of Internal Medicine. 119 (11): 1113–24. December 1993. doi:10.7326/0003-4819-119-11-199312010-00009. PMID 8239231. Diarkibkan daripada yang asal (PDF) pada 14 August 2017. Dicapai pada 4 July 2020.
"Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder". The Journal of Clinical Endocrinology and Metabolism. 93 (5): 1563–72. May 2008. doi:10.1210/jc.2008-0040. PMC 2386273. PMID 18319312.
"Antenatal dexamethasone and decreased birth weight". Obstetrics and Gynecology. 97 (4): 485–90. April 2001. doi:10.1016/S0029-7844(00)01206-0. PMID 11275014.
"Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint". The Journal of Clinical Endocrinology and Metabolism. 97 (6): 1881–83. June 2012. doi:10.1210/jc.2012-1222. PMID 22466333.
"Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone". The Journal of Clinical Endocrinology and Metabolism. 92 (2): 542–48. February 2007. doi:10.1210/jc.2006-1340. PMID 17148562.
"Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency". Endocrine Development. 20: 96–105. 2011. doi:10.1159/000321228. ISBN 978-3-8055-9643-5. PMID 21164263.
"Interventions for treating acute high altitude illness". Cochrane Database Syst Rev. 6 (12): CD009567. June 2018. doi:10.1002/14651858.CD009567.pub2. PMC 6513207. PMID 29959871.
"First-line therapy for hypertension". Annals of Internal Medicine. 146 (8): 615. April 2007. doi:10.7326/0003-4819-146-8-200704170-00021. PMID 17438328.
"Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis". Anaesthesia. 73 (4): 480–89. April 2018. doi:10.1111/anae.14166. PMID 29226971.
"Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies". The Annals of Pharmacotherapy. 40 (5): 873–87. May 2006. doi:10.1345/aph.1G338. PMID 16670361.
"Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials". BMJ. 358: j3887. September 2017. doi:10.1136/bmj.j3887. PMC 5605780. PMID 28931508. Unknown parameter |displayauthors= ignored (bantuan)
"Glucocorticoid action and the development of selective glucocorticoid receptor ligands". Biotechnol Annu Rev. Biotechnology Annual Review. 12: 269–300. 2006. doi:10.1016/S1387-2656(06)12008-6. ISBN 9780444527240. PMID 17045197.
"A Refill for the Brain Mineralocorticoid Receptor: The Benefit of Cortisol Add-On to Dexamethasone Therapy". Endocrinology. 158 (3): 448–454. March 2017. doi:10.1210/en.2016-1495. PMID 27967238.
"Antedrugs: an approach to safer drugs". Current Medicinal Chemistry. 12 (19): 2227–39. 2005. doi:10.2174/0929867054864840. PMID 16178782.
"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy". Allergy, Asthma, and Clinical Immunology. 9 (1): 30. August 2013. doi:10.1186/1710-1492-9-30. PMC 3765115. PMID 23947590.
"Why Dexamethasone Poorly Penetrates in Brain". Stress. 2 (1): 13–20. October 1997. doi:10.3109/10253899709014734. PMID 9787252.
"Dexamethasone at 119 K". Acta Crystallographica Section E. 63 (6): o2791–93. 2007. doi:10.1107/S1600536807020806.
"Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis". Journal of Mass Spectrometry. 37 (1): 69–75. January 2002. Bibcode:2002JMSp...37...69A. doi:10.1002/jms.260. PMID 11813313.
"16-Methylated steroids. II. 16α-Methyl analogs of cortisone, a new group of anti-inflammatory steroids. 9α-Halo derivatives". Journal of the American Chemical Society. 80 (12): 3161–63. 1958. doi:10.1021/ja01545a063.
"16β-Methyl cortical steroids". Journal of the American Chemical Society. 80 (16): 4435. 1958. doi:10.1021/ja01549a095.
"Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint". BMJ. 369: m2512. June 2020. doi:10.1136/bmj.m2512. PMID 32576548.
"Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report". New England Journal of Medicine. 384 (8): 693–704. July 2020. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530. Unknown parameter |displayauthors= ignored (bantuan)
"Dexamethasone in Hospitalized Patients with Covid-19". N Engl J Med. 384 (8): 693–704. February 2021. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530. Unknown parameter |displayauthors= ignored (bantuan)

drugs.com

"Dexamethasone Use During Pregnancy". Drugs.com. Diarkibkan daripada yang asal pada 17 May 2016. Dicapai pada 9 June 2016. Dexamethasone is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
"Dexamethasone". The American Society of Health-System Pharmacists. Diarkibkan daripada yang asal pada 31 August 2017. Dicapai pada 29 July 2015.

europa.eu

ema.europa.eu

"Ozurdex EPAR". European Medicines Agency (EMA). 17 September 2018. Diarkibkan daripada yang asal pada 27 October 2020. Dicapai pada 24 October 2020.
"Neofordex EPAR". European Medicines Agency (EMA). Dicapai pada 24 October 2020.^{[pautan mati kekal]}
"EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation" (Siaran akhbar). 18 September 2020. Diarkibkan daripada yang asal pada 14 February 2021. Dicapai pada 21 September 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support" (Siaran akhbar). 24 July 2020. Diarkibkan daripada yang asal pada 30 January 2021. Dicapai pada 27 July 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"EMA receives application for marketing authorisation of Dexamethasone Taw COVID-19". European Medicines Agency (EMA). 2 September 2020. Diarkibkan daripada yang asal pada 3 September 2020. Dicapai pada 2 September 2020.

fda.gov

accessdata.fda.gov

"Drugs@FDA: Dexamethasone". U.S. Food and Drug Administration (FDA). Diarkibkan daripada yang asal pada 30 November 2017. Dicapai pada 27 March 2022.

fda.gov

"Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Diarkibkan daripada yang asal pada 29 June 2023. Dicapai pada 29 June 2023.

gpni.co.uk

"Dexamethasone in COVID-19" (PDF). www.gpni.co.uk. 16 June 2020. Diarkibkan (PDF) daripada yang asal pada 17 June 2020. Dicapai pada 18 June 2020.

handle.net

hdl.handle.net

World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

harvard.edu

ui.adsabs.harvard.edu

"Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis". Journal of Mass Spectrometry. 37 (1): 69–75. January 2002. Bibcode:2002JMSp...37...69A. doi:10.1002/jms.260. PMID 11813313.

idsociety.org

"COVID-19 Guideline, Part 1: Treatment and Management". Infectious Diseases Society of America. Diarkibkan daripada yang asal pada 6 October 2020. Dicapai pada 22 July 2020. Recommendation 4. Among hospitalized people with severe* COVID-19, the IDSA guideline panel suggests glucocorticoids rather than no glucocorticoids. (Conditional recommendation, Moderate certainty of evidence)
Remark: Dexamethasone 6 mg IV or PO for 10 days (or until discharge if earlier) or equivalent glucocorticoid dose may be substituted if dexamethasone unavailable. Equivalent total daily doses of alternative glucocorticoids to dexamethasone 6 mg daily are methylprednisolone 32 mg and prednisone 40 mg.
Recommendation 5. Among hospitalized people with COVID-19 without hypoxemia requiring supplemental oxygen, the IDSA guideline panel suggests against the use of glucocorticoids. (Conditional recommendation, Low certainty of evidence)

jamanetwork.com

"Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic". JAMA. 324 (13): 1292–1295. September 2020. doi:10.1001/jama.2020.16747. PMID 32876693. Diarkibkan daripada yang asal pada 3 December 2020. Dicapai pada 2 September 2020.

mayoclinic.org

"Croup – Diagnosis & Treatment". Mayo Clinic. Diarkibkan daripada yang asal pada 10 October 2017. Dicapai pada 13 October 2017. Dexamethasone is usually recommended because of its long-lasting effects (up to 72 hours).

medicines.org.uk

"Dexamethasone Tablet BP 2.0 mg – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 26 January 2018. Diarkibkan daripada yang asal pada 17 June 2020. Dicapai pada 17 June 2020.
"Dexamethasone 4.0 mg/ml injection – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 4 December 2013. Diarkibkan daripada yang asal pada 8 May 2015. Dicapai pada 11 December 2013.

medscape.com

reference.medscape.com

"Decadron, Dexamethasone Intensol (dexamethasone) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Diarkibkan daripada yang asal pada 12 December 2013. Dicapai pada 11 December 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Dogra P, Vijayashankar NP (September 14, 2020). "Dexamethasone Suppression Test". StatPearls (September 14, 2020). PMID 31194457.
Jobe AH, Milad MA, Peppard T, Jusko WJ (March 2020). "Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India". Clinical and Translational Science. 13 (2): 391–99. doi:10.1111/cts.12724. PMC 7070803. PMID 31808984.
"International consensus report on the investigation and management of primary immune thrombocytopenia". Blood. 115 (2): 168–86. January 2010. doi:10.1182/blood-2009-06-225565. PMID 19846889. Unknown parameter |displayauthors= ignored (bantuan)
"Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth". European Journal of Clinical Pharmacology. 44 (3): 275–77. 1993. doi:10.1007/BF00271371. PMID 8491244.
"Corticosteroid implants for chronic non-infectious uveitis". The Cochrane Database of Systematic Reviews. 1 (1): CD010469. January 2023. doi:10.1002/14651858.CD010469.pub3. PMC 9841887 Check |pmc= value (bantuan). PMID 36645716 Check |pmid= value (bantuan).
"Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure". The Cochrane Database of Systematic Reviews. 2022 (6): CD012131. June 2022. doi:10.1002/14651858.CD012131.pub3. PMC 9169535 Check |pmc= value (bantuan). PMID 35665485 Check |pmid= value (bantuan).
"Corticosteroids for acute bacterial meningitis". Cochrane Database of Systematic Reviews. 2015 (9): CD004405. September 2015. doi:10.1002/14651858.CD004405.pub5. PMC 6491272. PMID 26362566.
"Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy". The New England Journal of Medicine. 342 (21): 1554–59. May 2000. doi:10.1056/NEJM200005253422102. PMID 10824073.
"Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications". Journal of the American College of Surgeons. 195 (5): 694–712. November 2002. doi:10.1016/s1072-7515(02)01491-6. PMID 12437261.
"Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?". J Neurooncol. 144 (2): 249–264. September 2019. doi:10.1007/s11060-019-03238-4. PMC 6700052. PMID 31346902.
"Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study". Haematologica. 91 (11): 1498–505. November 2006. PMID 17043025. Unknown parameter |displayauthors= ignored (bantuan)
"Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis". JAMA. 324 (13): 1330–1341. September 2020. doi:10.1001/jama.2020.17023. PMC 7489434. PMID 32876694. Unknown parameter |displayauthors= ignored (bantuan)
"Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic". JAMA. 324 (13): 1292–1295. September 2020. doi:10.1001/jama.2020.16747. PMID 32876693. Diarkibkan daripada yang asal pada 3 December 2020. Dicapai pada 2 September 2020.
"Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set". Critical Care. 26 (1): 236. August 2022. doi:10.1186/s13054-022-04108-8. PMC 9347163 Check |pmc= value (bantuan). PMID 35922860 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists". Intensive Care Medicine. 48 (7): 954–957. July 2022. doi:10.1007/s00134-022-06750-w. PMC 9171741 Check |pmc= value (bantuan). PMID 35670819 Check |pmid= value (bantuan).
"Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study". Critical Care. 26 (1): 176. June 2022. doi:10.1186/s13054-022-04049-2. PMC 9191402 Check |pmc= value (bantuan). PMID 35698155 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Ventilator-associated pneumonia in critically ill patients with COVID-19". Critical Care. 25 (1): 25. January 2021. doi:10.1186/s13054-021-03460-5. PMC 7797892. PMID 33430915. Unknown parameter |displayauthors= ignored (bantuan)
"Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19". Nature Medicine. 28 (1): 201–211. January 2022. doi:10.1038/s41591-021-01576-3. PMC 8799469 Check |pmc= value (bantuan). PMID 34782790 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Adverse side effects of dexamethasone in surgical patients". The Cochrane Database of Systematic Reviews. 11 (11): CD011940. November 2018. doi:10.1002/14651858.CD011940.pub3. PMC 6426282. PMID 30480776. Unknown parameter |displayauthors= ignored (bantuan)
"Syndromes of glucocorticoid resistance" (PDF). Annals of Internal Medicine. 119 (11): 1113–24. December 1993. doi:10.7326/0003-4819-119-11-199312010-00009. PMID 8239231. Diarkibkan daripada yang asal (PDF) pada 14 August 2017. Dicapai pada 4 July 2020.
"Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder". The Journal of Clinical Endocrinology and Metabolism. 93 (5): 1563–72. May 2008. doi:10.1210/jc.2008-0040. PMC 2386273. PMID 18319312.
"Antenatal dexamethasone and decreased birth weight". Obstetrics and Gynecology. 97 (4): 485–90. April 2001. doi:10.1016/S0029-7844(00)01206-0. PMID 11275014.
"Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint". The Journal of Clinical Endocrinology and Metabolism. 97 (6): 1881–83. June 2012. doi:10.1210/jc.2012-1222. PMID 22466333.
"Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone". The Journal of Clinical Endocrinology and Metabolism. 92 (2): 542–48. February 2007. doi:10.1210/jc.2006-1340. PMID 17148562.
"Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency". Endocrine Development. 20: 96–105. 2011. doi:10.1159/000321228. ISBN 978-3-8055-9643-5. PMID 21164263.
"Interventions for treating acute high altitude illness". Cochrane Database Syst Rev. 6 (12): CD009567. June 2018. doi:10.1002/14651858.CD009567.pub2. PMC 6513207. PMID 29959871.
"First-line therapy for hypertension". Annals of Internal Medicine. 146 (8): 615. April 2007. doi:10.7326/0003-4819-146-8-200704170-00021. PMID 17438328.
"Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis". Anaesthesia. 73 (4): 480–89. April 2018. doi:10.1111/anae.14166. PMID 29226971.
"Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies". The Annals of Pharmacotherapy. 40 (5): 873–87. May 2006. doi:10.1345/aph.1G338. PMID 16670361.
"Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials". BMJ. 358: j3887. September 2017. doi:10.1136/bmj.j3887. PMC 5605780. PMID 28931508. Unknown parameter |displayauthors= ignored (bantuan)
"Glucocorticoid action and the development of selective glucocorticoid receptor ligands". Biotechnol Annu Rev. Biotechnology Annual Review. 12: 269–300. 2006. doi:10.1016/S1387-2656(06)12008-6. ISBN 9780444527240. PMID 17045197.
"A Refill for the Brain Mineralocorticoid Receptor: The Benefit of Cortisol Add-On to Dexamethasone Therapy". Endocrinology. 158 (3): 448–454. March 2017. doi:10.1210/en.2016-1495. PMID 27967238.
De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Nicolaides NC, Pavlaki AN, Maria Alexandra MA, Chrousos GP (2000). "Endotext". Glucocorticoid Therapy and Adrenal Suppression. MDText.com. PMID 25905379. Diarkibkan daripada yang asal pada 1 July 2020. Dicapai pada 17 June 2020.
"Antedrugs: an approach to safer drugs". Current Medicinal Chemistry. 12 (19): 2227–39. 2005. doi:10.2174/0929867054864840. PMID 16178782.
"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy". Allergy, Asthma, and Clinical Immunology. 9 (1): 30. August 2013. doi:10.1186/1710-1492-9-30. PMC 3765115. PMID 23947590.
"Why Dexamethasone Poorly Penetrates in Brain". Stress. 2 (1): 13–20. October 1997. doi:10.3109/10253899709014734. PMID 9787252.
"Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis". Journal of Mass Spectrometry. 37 (1): 69–75. January 2002. Bibcode:2002JMSp...37...69A. doi:10.1002/jms.260. PMID 11813313.
"Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint". BMJ. 369: m2512. June 2020. doi:10.1136/bmj.m2512. PMID 32576548.
"Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report". New England Journal of Medicine. 384 (8): 693–704. July 2020. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530. Unknown parameter |displayauthors= ignored (bantuan)
"Dexamethasone in Hospitalized Patients with Covid-19". N Engl J Med. 384 (8): 693–704. February 2021. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530. Unknown parameter |displayauthors= ignored (bantuan)

ncbi.nlm.nih.gov

Jobe AH, Milad MA, Peppard T, Jusko WJ (March 2020). "Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India". Clinical and Translational Science. 13 (2): 391–99. doi:10.1111/cts.12724. PMC 7070803. PMID 31808984.
"Corticosteroid implants for chronic non-infectious uveitis". The Cochrane Database of Systematic Reviews. 1 (1): CD010469. January 2023. doi:10.1002/14651858.CD010469.pub3. PMC 9841887 Check |pmc= value (bantuan). PMID 36645716 Check |pmid= value (bantuan).
"Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure". The Cochrane Database of Systematic Reviews. 2022 (6): CD012131. June 2022. doi:10.1002/14651858.CD012131.pub3. PMC 9169535 Check |pmc= value (bantuan). PMID 35665485 Check |pmid= value (bantuan).
"Corticosteroids for acute bacterial meningitis". Cochrane Database of Systematic Reviews. 2015 (9): CD004405. September 2015. doi:10.1002/14651858.CD004405.pub5. PMC 6491272. PMID 26362566.
"Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?". J Neurooncol. 144 (2): 249–264. September 2019. doi:10.1007/s11060-019-03238-4. PMC 6700052. PMID 31346902.
"Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis". JAMA. 324 (13): 1330–1341. September 2020. doi:10.1001/jama.2020.17023. PMC 7489434. PMID 32876694. Unknown parameter |displayauthors= ignored (bantuan)
"Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set". Critical Care. 26 (1): 236. August 2022. doi:10.1186/s13054-022-04108-8. PMC 9347163 Check |pmc= value (bantuan). PMID 35922860 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists". Intensive Care Medicine. 48 (7): 954–957. July 2022. doi:10.1007/s00134-022-06750-w. PMC 9171741 Check |pmc= value (bantuan). PMID 35670819 Check |pmid= value (bantuan).
"Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study". Critical Care. 26 (1): 176. June 2022. doi:10.1186/s13054-022-04049-2. PMC 9191402 Check |pmc= value (bantuan). PMID 35698155 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Ventilator-associated pneumonia in critically ill patients with COVID-19". Critical Care. 25 (1): 25. January 2021. doi:10.1186/s13054-021-03460-5. PMC 7797892. PMID 33430915. Unknown parameter |displayauthors= ignored (bantuan)
"Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19". Nature Medicine. 28 (1): 201–211. January 2022. doi:10.1038/s41591-021-01576-3. PMC 8799469 Check |pmc= value (bantuan). PMID 34782790 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Adverse side effects of dexamethasone in surgical patients". The Cochrane Database of Systematic Reviews. 11 (11): CD011940. November 2018. doi:10.1002/14651858.CD011940.pub3. PMC 6426282. PMID 30480776. Unknown parameter |displayauthors= ignored (bantuan)
"Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder". The Journal of Clinical Endocrinology and Metabolism. 93 (5): 1563–72. May 2008. doi:10.1210/jc.2008-0040. PMC 2386273. PMID 18319312.
"Interventions for treating acute high altitude illness". Cochrane Database Syst Rev. 6 (12): CD009567. June 2018. doi:10.1002/14651858.CD009567.pub2. PMC 6513207. PMID 29959871.
"Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials". BMJ. 358: j3887. September 2017. doi:10.1136/bmj.j3887. PMC 5605780. PMID 28931508. Unknown parameter |displayauthors= ignored (bantuan)
De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Nicolaides NC, Pavlaki AN, Maria Alexandra MA, Chrousos GP (2000). "Endotext". Glucocorticoid Therapy and Adrenal Suppression. MDText.com. PMID 25905379. Diarkibkan daripada yang asal pada 1 July 2020. Dicapai pada 17 June 2020.
"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy". Allergy, Asthma, and Clinical Immunology. 9 (1): 30. August 2013. doi:10.1186/1710-1492-9-30. PMC 3765115. PMID 23947590.
"Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report". New England Journal of Medicine. 384 (8): 693–704. July 2020. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530. Unknown parameter |displayauthors= ignored (bantuan)
"Dexamethasone in Hospitalized Patients with Covid-19". N Engl J Med. 384 (8): 693–704. February 2021. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530. Unknown parameter |displayauthors= ignored (bantuan)

dailymed.nlm.nih.gov

"Ozurdex- dexamethasone implant". DailyMed. 30 October 2020. Diarkibkan daripada yang asal pada 27 March 2022. Dicapai pada 27 March 2022.
"Dexamethasone sodium phosphate solution/ drops". DailyMed. 31 July 2020. Diarkibkan daripada yang asal pada 27 January 2022. Dicapai pada 27 March 2022.
"Dexycu- dexamethasone injection, suspension". DailyMed. 20 December 2021. Diarkibkan daripada yang asal pada 27 March 2022. Dicapai pada 27 March 2022.
"Dexamethasone tablet [ECR Pharmaceuticals]". DailyMed. ECR Pharmaceuticals. December 2010. Diarkibkan daripada yang asal pada 13 December 2013. Dicapai pada 11 December 2013.

covid19treatmentguidelines.nih.gov

"Corticosteroids". COVID-19 Treatment Guidelines. National Institutes of Health. Diarkibkan daripada yang asal pada 19 July 2020. Dicapai pada 12 July 2020.

operationalmedicine.org

Cymerman A, Rock PB (1994). Medical Problems in High Mountain Environments. A Handbook for Medical Officers (PDF). USARIEM-TN94-2. US Army Research Inst. of Environmental Medicine Thermal and Mountain Medicine Division Technical Report. Diarkibkan daripada yang asal (PDF) pada 17 June 2017. Dicapai pada 17 June 2020.

ox.ac.uk

"Dexamethasone reduces death in hospitalized people with severe respiratory complications of COVID-19". University of Oxford. 16 June 2020. Diarkibkan daripada yang asal pada 16 June 2020. Dicapai pada 16 June 2020.

paramedic-info.com

"Paramedic Clinical Training Aid". Diarkibkan daripada yang asal pada 31 March 2012. Dicapai pada 30 August 2011.

reuters.com

"Important to use dexamethasone only for serious COVID cases – WHO". 17 June 2020. Diarkibkan daripada yang asal pada 17 June 2020. Dicapai pada 18 June 2020.
"EMA to review results from study testing common steroid drug against COVID-19". Reuters. 24 July 2020. Diarkibkan daripada yang asal pada 27 July 2020. Dicapai pada 27 July 2020.

sps.nhs.uk

"Dexamethasone and COVID-19". SPS – Specialist Pharmacy Service. Diarkibkan daripada yang asal pada 22 July 2020. Dicapai pada 2020-07-22.

targetcivils.in

"Dexamethasone". 17 June 2020. Diarkibkan daripada yang asal pada 1 October 2020. Dicapai pada 18 June 2020.

tga.gov.au

"DEXAMETHASONE JUNO (Juno Pharmaceuticals Pty Ltd)". Department of Health and Aged Care. Diarkibkan daripada yang asal pada 2023-03-18.
"Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. Diarkibkan daripada yang asal pada 8 April 2014. Dicapai pada 22 April 2014. Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.

ebs.tga.gov.au

"Product Information Dexamethsone (dexamethasone)" (PDF). TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. 10 August 2010. Diarkibkan daripada yang asal pada 28 January 2017. Dicapai pada 11 December 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)
"Product Information Dexmethsone Injection" (PDF). TGA eBusiness ServicesAspen Pharmacare Australia Pty Ltd. Aspen Pharmacare Australia Pty Ltd. 2 March 2011. Diarkibkan daripada yang asal pada 29 January 2017. Dicapai pada 11 December 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)

time.com

content.time.com

"A Prenatal Treatment Raises Questions of Medical Ethics". 18 June 2010. Diarkibkan daripada yang asal pada 31 August 2016 – melalui content.time.com.

wada-ama.org

"Prohibited In-Competition: Glucocorticoids". World Anti-Doping Agency. Diarkibkan daripada yang asal pada 16 July 2018. Dicapai pada 16 July 2018.

web.archive.org

"Dexamethasone Use During Pregnancy". Drugs.com. Diarkibkan daripada yang asal pada 17 May 2016. Dicapai pada 9 June 2016. Dexamethasone is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
"DEXAMETHASONE JUNO (Juno Pharmaceuticals Pty Ltd)". Department of Health and Aged Care. Diarkibkan daripada yang asal pada 2023-03-18.
"Ozurdex- dexamethasone implant". DailyMed. 30 October 2020. Diarkibkan daripada yang asal pada 27 March 2022. Dicapai pada 27 March 2022.
"Dexamethasone sodium phosphate solution/ drops". DailyMed. 31 July 2020. Diarkibkan daripada yang asal pada 27 January 2022. Dicapai pada 27 March 2022.
"Dexycu- dexamethasone injection, suspension". DailyMed. 20 December 2021. Diarkibkan daripada yang asal pada 27 March 2022. Dicapai pada 27 March 2022.
"Ozurdex EPAR". European Medicines Agency (EMA). 17 September 2018. Diarkibkan daripada yang asal pada 27 October 2020. Dicapai pada 24 October 2020.
"Dexamethasone". The American Society of Health-System Pharmacists. Diarkibkan daripada yang asal pada 31 August 2017. Dicapai pada 29 July 2015.
"Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. Diarkibkan daripada yang asal pada 8 April 2014. Dicapai pada 22 April 2014. Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.
"Drugs@FDA: Dexamethasone". U.S. Food and Drug Administration (FDA). Diarkibkan daripada yang asal pada 30 November 2017. Dicapai pada 27 March 2022.
Rankovic Z, Hargreaves R, Bingham M (2012). Drug discovery and medicinal chemistry for psychiatric disorders. Cambridge: Royal Society of Chemistry. m/s. 286. ISBN 9781849733656. Diarkibkan daripada yang asal pada 5 March 2016.
Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. m/s. 485. ISBN 9783527607495. Diarkibkan daripada yang asal pada 10 January 2023. Dicapai pada 17 June 2020.
"The Top 300 of 2020". ClinCalc. Diarkibkan daripada yang asal pada 12 February 2021. Dicapai pada 7 October 2022.
"Dexamethasone – Drug Usage Statistics". ClinCalc. Diarkibkan daripada yang asal pada 12 April 2020. Dicapai pada 7 October 2022.
"Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Diarkibkan daripada yang asal pada 29 June 2023. Dicapai pada 29 June 2023.
"Paramedic Clinical Training Aid". Diarkibkan daripada yang asal pada 31 March 2012. Dicapai pada 30 August 2011.
"Croup – Diagnosis & Treatment". Mayo Clinic. Diarkibkan daripada yang asal pada 10 October 2017. Dicapai pada 13 October 2017. Dexamethasone is usually recommended because of its long-lasting effects (up to 72 hours).
"Dexamethasone and COVID-19". SPS – Specialist Pharmacy Service. Diarkibkan daripada yang asal pada 22 July 2020. Dicapai pada 2020-07-22.
"Corticosteroids". COVID-19 Treatment Guidelines. National Institutes of Health. Diarkibkan daripada yang asal pada 19 July 2020. Dicapai pada 12 July 2020.
"COVID-19 Guideline, Part 1: Treatment and Management". Infectious Diseases Society of America. Diarkibkan daripada yang asal pada 6 October 2020. Dicapai pada 22 July 2020. Recommendation 4. Among hospitalized people with severe* COVID-19, the IDSA guideline panel suggests glucocorticoids rather than no glucocorticoids. (Conditional recommendation, Moderate certainty of evidence)
Remark: Dexamethasone 6 mg IV or PO for 10 days (or until discharge if earlier) or equivalent glucocorticoid dose may be substituted if dexamethasone unavailable. Equivalent total daily doses of alternative glucocorticoids to dexamethasone 6 mg daily are methylprednisolone 32 mg and prednisone 40 mg.
Recommendation 5. Among hospitalized people with COVID-19 without hypoxemia requiring supplemental oxygen, the IDSA guideline panel suggests against the use of glucocorticoids. (Conditional recommendation, Low certainty of evidence)
"Dexamethasone reduces death in hospitalized people with severe respiratory complications of COVID-19". University of Oxford. 16 June 2020. Diarkibkan daripada yang asal pada 16 June 2020. Dicapai pada 16 June 2020.
"Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic". JAMA. 324 (13): 1292–1295. September 2020. doi:10.1001/jama.2020.16747. PMID 32876693. Diarkibkan daripada yang asal pada 3 December 2020. Dicapai pada 2 September 2020.
"EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation" (Siaran akhbar). 18 September 2020. Diarkibkan daripada yang asal pada 14 February 2021. Dicapai pada 21 September 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Syndromes of glucocorticoid resistance" (PDF). Annals of Internal Medicine. 119 (11): 1113–24. December 1993. doi:10.7326/0003-4819-119-11-199312010-00009. PMID 8239231. Diarkibkan daripada yang asal (PDF) pada 14 August 2017. Dicapai pada 4 July 2020.
"A Prenatal Treatment Raises Questions of Medical Ethics". 18 June 2010. Diarkibkan daripada yang asal pada 31 August 2016 – melalui content.time.com.
Cymerman A, Rock PB (1994). Medical Problems in High Mountain Environments. A Handbook for Medical Officers (PDF). USARIEM-TN94-2. US Army Research Inst. of Environmental Medicine Thermal and Mountain Medicine Division Technical Report. Diarkibkan daripada yang asal (PDF) pada 17 June 2017. Dicapai pada 17 June 2020.
"Decadron, Dexamethasone Intensol (dexamethasone) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Diarkibkan daripada yang asal pada 12 December 2013. Dicapai pada 11 December 2013.
"Product Information Dexamethsone (dexamethasone)" (PDF). TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. 10 August 2010. Diarkibkan daripada yang asal pada 28 January 2017. Dicapai pada 11 December 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)
"Product Information Dexmethsone Injection" (PDF). TGA eBusiness ServicesAspen Pharmacare Australia Pty Ltd. Aspen Pharmacare Australia Pty Ltd. 2 March 2011. Diarkibkan daripada yang asal pada 29 January 2017. Dicapai pada 11 December 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)
"Dexamethasone tablet [ECR Pharmaceuticals]". DailyMed. ECR Pharmaceuticals. December 2010. Diarkibkan daripada yang asal pada 13 December 2013. Dicapai pada 11 December 2013.
"Dexamethasone Tablet BP 2.0 mg – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 26 January 2018. Diarkibkan daripada yang asal pada 17 June 2020. Dicapai pada 17 June 2020.
"Dexamethasone 4.0 mg/ml injection – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 4 December 2013. Diarkibkan daripada yang asal pada 8 May 2015. Dicapai pada 11 December 2013.
De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Nicolaides NC, Pavlaki AN, Maria Alexandra MA, Chrousos GP (2000). "Endotext". Glucocorticoid Therapy and Adrenal Suppression. MDText.com. PMID 25905379. Diarkibkan daripada yang asal pada 1 July 2020. Dicapai pada 17 June 2020.
Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. m/s. 366–. ISBN 978-1-4757-2085-3. Diarkibkan daripada yang asal pada 15 February 2017.
Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. m/s. 310–. ISBN 978-3-88763-075-1. Diarkibkan daripada yang asal pada 24 August 2017.
"Dexamethasone". 17 June 2020. Diarkibkan daripada yang asal pada 1 October 2020. Dicapai pada 18 June 2020.
"Dexamethasone in COVID-19" (PDF). www.gpni.co.uk. 16 June 2020. Diarkibkan (PDF) daripada yang asal pada 17 June 2020. Dicapai pada 18 June 2020.
"Important to use dexamethasone only for serious COVID cases – WHO". 17 June 2020. Diarkibkan daripada yang asal pada 17 June 2020. Dicapai pada 18 June 2020.
"WHO Director-General's opening remarks at the media briefing on COVID-19". World Health Organization. 22 June 2020. Diarkibkan daripada yang asal pada 12 September 2020. Dicapai pada 26 June 2020.
"Q&A: Dexamethasone and COVID-19". World Health Organization (WHO). Diarkibkan daripada yang asal pada 11 October 2020. Dicapai pada 12 July 2020.
"WHO updates clinical care guidance with corticosteroid recommendations" (Siaran akhbar). 2 September 2020. Diarkibkan daripada yang asal pada 6 May 2021. Dicapai pada 27 March 2022.
"EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support" (Siaran akhbar). 24 July 2020. Diarkibkan daripada yang asal pada 30 January 2021. Dicapai pada 27 July 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"EMA to review results from study testing common steroid drug against COVID-19". Reuters. 24 July 2020. Diarkibkan daripada yang asal pada 27 July 2020. Dicapai pada 27 July 2020.
"EMA receives application for marketing authorisation of Dexamethasone Taw COVID-19". European Medicines Agency (EMA). 2 September 2020. Diarkibkan daripada yang asal pada 3 September 2020. Dicapai pada 2 September 2020.
"Dexamethasone for Accelerating Lung Maturation in Preterm Babies" (PDF). Diarkibkan (PDF) daripada yang asal pada 22 December 2015. Dicapai pada 29 July 2015.
"Bangladesh's dark brothel steroid secret". BBC News Online. 30 May 2010. Diarkibkan daripada yang asal pada 22 February 2012.
"Prohibited In-Competition: Glucocorticoids". World Anti-Doping Agency. Diarkibkan daripada yang asal pada 16 July 2018. Dicapai pada 16 July 2018.
"Trichlormethiazide and Dexamethasone for veterinary use". Wedgewood Pharmacy. Diarkibkan daripada yang asal pada 12 December 2007. Dicapai pada 23 January 2008.

wedgewoodpharmacy.com

"Trichlormethiazide and Dexamethasone for veterinary use". Wedgewood Pharmacy. Diarkibkan daripada yang asal pada 12 December 2007. Dicapai pada 23 January 2008.

who.int

"WHO Director-General's opening remarks at the media briefing on COVID-19". World Health Organization. 22 June 2020. Diarkibkan daripada yang asal pada 12 September 2020. Dicapai pada 26 June 2020.
"Q&A: Dexamethasone and COVID-19". World Health Organization (WHO). Diarkibkan daripada yang asal pada 11 October 2020. Dicapai pada 12 July 2020.
"WHO updates clinical care guidance with corticosteroid recommendations" (Siaran akhbar). 2 September 2020. Diarkibkan daripada yang asal pada 6 May 2021. Dicapai pada 27 March 2022.
"Dexamethasone for Accelerating Lung Maturation in Preterm Babies" (PDF). Diarkibkan (PDF) daripada yang asal pada 22 December 2015. Dicapai pada 29 July 2015.

wikipedia.org

en.wikipedia.org

"International consensus report on the investigation and management of primary immune thrombocytopenia". Blood. 115 (2): 168–86. January 2010. doi:10.1182/blood-2009-06-225565. PMID 19846889. Unknown parameter |displayauthors= ignored (bantuan)
"Corticosteroid implants for chronic non-infectious uveitis". The Cochrane Database of Systematic Reviews. 1 (1): CD010469. January 2023. doi:10.1002/14651858.CD010469.pub3. PMC 9841887 Check |pmc= value (bantuan). PMID 36645716 Check |pmid= value (bantuan).
"Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure". The Cochrane Database of Systematic Reviews. 2022 (6): CD012131. June 2022. doi:10.1002/14651858.CD012131.pub3. PMC 9169535 Check |pmc= value (bantuan). PMID 35665485 Check |pmid= value (bantuan).
"Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study". Haematologica. 91 (11): 1498–505. November 2006. PMID 17043025. Unknown parameter |displayauthors= ignored (bantuan)
(Laporan). 2020. Diarkibkan daripada yang asal |archive-url= requires |url= (bantuan) pada 11 October 2020. Missing or empty |title= (bantuan)
"Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis". JAMA. 324 (13): 1330–1341. September 2020. doi:10.1001/jama.2020.17023. PMC 7489434. PMID 32876694. Unknown parameter |displayauthors= ignored (bantuan)
"Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set". Critical Care. 26 (1): 236. August 2022. doi:10.1186/s13054-022-04108-8. PMC 9347163 Check |pmc= value (bantuan). PMID 35922860 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists". Intensive Care Medicine. 48 (7): 954–957. July 2022. doi:10.1007/s00134-022-06750-w. PMC 9171741 Check |pmc= value (bantuan). PMID 35670819 Check |pmid= value (bantuan).
"Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study". Critical Care. 26 (1): 176. June 2022. doi:10.1186/s13054-022-04049-2. PMC 9191402 Check |pmc= value (bantuan). PMID 35698155 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Ventilator-associated pneumonia in critically ill patients with COVID-19". Critical Care. 25 (1): 25. January 2021. doi:10.1186/s13054-021-03460-5. PMC 7797892. PMID 33430915. Unknown parameter |displayauthors= ignored (bantuan)
"Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19". Nature Medicine. 28 (1): 201–211. January 2022. doi:10.1038/s41591-021-01576-3. PMC 8799469 Check |pmc= value (bantuan). PMID 34782790 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Adverse side effects of dexamethasone in surgical patients". The Cochrane Database of Systematic Reviews. 11 (11): CD011940. November 2018. doi:10.1002/14651858.CD011940.pub3. PMC 6426282. PMID 30480776. Unknown parameter |displayauthors= ignored (bantuan)
"Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials". BMJ. 358: j3887. September 2017. doi:10.1136/bmj.j3887. PMC 5605780. PMID 28931508. Unknown parameter |displayauthors= ignored (bantuan)
"Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report". New England Journal of Medicine. 384 (8): 693–704. July 2020. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530. Unknown parameter |displayauthors= ignored (bantuan)
"Dexamethasone in Hospitalized Patients with Covid-19". N Engl J Med. 384 (8): 693–704. February 2021. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530. Unknown parameter |displayauthors= ignored (bantuan)